Search results for "Vascular resection"

showing 3 items of 3 documents

Robotic-assisted pancreaticoduodenectomy with vascular resection. Description of the surgical technique and analysis of early outcomes

2019

Abstract Background Despite the potential benefits, the adoption of the minimally invasive surgery for the treatment of borderline resectable pancreatic cancer is still in the initial phase. We investigated the safety and feasibility of the robotic pancreaticoduodenectomy with venous resection/reconstruction (RPD SMV/PV). Methods Since March 2013 to October 2019, a total of 73 RPD and 10 RPD SMV/PV were performed. The two groups were case-matched according to the preoperative characteristics. Results Mean operative times and estimated blood loss were less in the RPD group in comparison to that in the RPD with SMV-PV group (525 vs 642 min, p = 0.003 and 290 vs 620 ml, p = 0.002, respectively…

Malemedicine.medical_specialtyRobotic assistedmedicine.medical_treatmentOperative TimeAdenocarcinoma030230 surgeryPancreaticoduodenectomy03 medical and health sciences0302 clinical medicineRobotic Surgical ProceduresBorderline resectablePancreatic cancerVascular reconstructionHumansMedicineRobotic surgeryVascular resectionAgedbusiness.industryMortality rateSurgical outcomesRobotic surgeryMiddle Agedmedicine.diseasePancreaticoduodenectomySurgeryPancreatic NeoplasmsTreatment OutcomeOncology030220 oncology & carcinogenesisInitial phaseFemaleSurgerybusinessVascular Surgical Procedures
researchProduct

Tangential Venous Resections during Robotic-Assisted Pancreaticoduodenectomy: the Results of a Case Series (with Video)

2020

Introduction: Despite the potential advantages in terms of microdissection and microsuturing capabilites, the robotic approach for borderline resectable pancreatic cancer is scarcely reported. Methods: We report our technique for a robotic-assisted pancreaticoduodenectomy with tangential Portal/ Superior Mesenteric Vein resection/reconstruction (RPD PV/SMV).We also compared the surgical outcomes of eight consecutive patients undergoing RPD PV/SMV with that of sixty patients who underwent robotic-assisted pancreaticoduodenectomy (RPD) in the same period of time. Results: A total of eight consecutive patients underwent RPD PV/SMV. We observed an increased estimated blood loss (550 vs 280 mL, …

medicine.medical_specialtyRobotic assistedmedicine.medical_treatmentPancreaticoduodenectomyResection03 medical and health sciencesMesenteric VeinsPancreatectomy0302 clinical medicineRobotic Surgical ProceduresBlood lossBorderline resectablemedicineHumansSuperior mesenteric veinRetrospective StudiesPortal Veinbusiness.industryGastroenterologyPancreaticoduodenectomyVascular resectionSurgeryPancreatic NeoplasmsVideo techniqueTreatment Outcome030220 oncology & carcinogenesisOperative time030211 gastroenterology & hepatologySurgeryRobotic-assisted pancreaticoduodenectomybusinessHospital stay
researchProduct

Strategie des chirurgischen Vorgehens beim hilären Cholangiokarzinom

2006

Surgery is the decisive life-prolonging treatment in patients with hilar cholangiocarcinoma. Surgery is mainly based on empiric data. Since patients without surgery have only about 6 months to survive, to achieve a high resection rate is crucial for these patients. During diagnostic workup, percutaneous transhepatic cholangiography results in the most reliable assessment of longitudinal tumor growth. The extent of the tumor is frequently overestimated leading to the consequence of excluding the patients from surgery. En-bloc resection of the tumor and the adjacent liver should be the preferred surgical approach. So far, surgical radicality (right trisegmentectomy, extended lymphadenectomy a…

medicine.medical_specialtySurgical approachbusiness.industrymedicine.medical_treatmentOperative mortalityPercutaneous transhepatic cholangiographySurgerymedicine.anatomical_structuremedicineSurgeryTumor growthIn patientVascular resectionbusinessLymph nodeMedian survivalZentralblatt für Chirurgie
researchProduct